Breakdown | |||||
TTM | Sep 2024 | Sep 2023 | Sep 2022 | Sep 2021 | Sep 2020 |
---|---|---|---|---|---|
Income Statement | Total Revenue | ||||
153.35M | 158.19M | 90.39M | 80.51M | 66.63M | 20.74M | Gross Profit |
21.54M | 27.89M | 23.34M | 20.08M | 16.25M | 5.71M | EBIT |
-2.84M | -787.00K | 3.33M | 2.34M | 3.44M | 1.97M | EBITDA |
-2.06M | 332.00K | 5.87M | 5.61M | 5.90M | 804.93K | Net Income Common Stockholders |
-14.52M | -12.49M | -1.70M | -111.51K | 1.50M | 27.92K |
Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | ||||
1.65M | 1.50M | 1.15M | 5.12M | 2.68M | 1.23M | Total Assets |
90.37M | 73.72M | 56.71M | 57.09M | 39.13M | 8.72M | Total Debt |
47.33M | 49.85M | 27.27M | 22.84M | 12.30M | 2.73M | Net Debt |
45.69M | 48.36M | 26.12M | 17.71M | 9.62M | 1.50M | Total Liabilities |
75.63M | 69.64M | 40.27M | 38.62M | 21.81M | 4.85M | Stockholders Equity |
14.75M | 4.08M | 16.44M | 18.47M | 17.32M | 3.87M |
Cash Flow | Free Cash Flow | ||||
3.66M | 3.02M | -3.20M | 3.38M | 24.13K | 479.20K | Operating Cash Flow |
6.65M | 5.93M | -1.27M | 4.04M | 1.97M | 804.89K | Investing Cash Flow |
-3.98M | -26.43M | -3.33M | -12.67M | -16.08M | 894.94K | Financing Cash Flow |
-3.42M | 20.85M | 625.00K | 11.07M | 15.56M | -424.55K |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
68 Neutral | $1.01B | 17.86 | 3.80% | ― | 35.87% | ― | |
53 Neutral | $1.05B | ― | -23.33% | ― | 0.67% | 19.14% | |
52 Neutral | C$131.31M | ― | -23.20% | ― | -8.80% | 26.77% | |
49 Neutral | $6.93B | 0.23 | -53.86% | 2.46% | 21.78% | -1.36% | |
44 Neutral | C$3.33M | ― | -160.58% | ― | 44.96% | -827.30% | |
32 Underperform | $301.07M | ― | -84.50% | ― | -16.27% | 76.17% |
Premier Health of America Inc. reported a challenging first quarter for 2025, with revenues declining to $32.1 million from $37 million in the same period the previous year. The company faced a net loss of $2.3 million, largely due to decreased adjusted EBITDA and increased financial expenses. The implementation of Quebec’s Bill 10, which imposes restrictions on independent labor, significantly impacted the Per Diem segment, now representing only 5% of revenues. Despite these challenges, the company is actively reorganizing its Quebec operations, reducing workforce, and terminating office leases to improve cost efficiency. The CEO remains optimistic about future improvements in operational efficiency and cost reduction.